Loading patent…
AssigneeSichuan Yingrui Pharmaceutical Technology Company
InventorsXiaohai Tang, Yu Qiu, Yuanfang Huang, Pingfang Xia
Estimating the term…
The present invention provides a nanocarbon-iron composite system which is a composite structure formed by interaction of acid-treated nanocarbon serving as a carrier, with and ferrous ions and/or ferric ions in an iron salt. In an in-vitro experiment and an animal experiment, the nanocarbon-iron composite system of the present invention shows a very efficient inhibition effect on solid tumors containing liver cancer, breast cancer and cervical cancer and has an excellent targeting property. Accordingly, the present invention further provides a preparation method of the nanocarbon-iron composite system, use of the nanocarbon-iron composite system in preparation of a drug for treating solid tumors, and a suspension for injection based on the nanocarbon-iron composite system.
A nanocarbon-iron composite system being a composite structure which is formed by acid-treated nanocarbon serving as a carrier, and the nanocarbon contains a certain amount of carboxyl on the surface, and ferrous ions and/or ferric ions in an iron salt, wherein the carboxyl has a content range of 0.03 mmol/g-0.08 mmol/g, wherein the composite system has a particle size of 90-300 nm.
A suspension for injection, comprising a nanocarbon-iron composite system being a composite structure which is formed by acid-treated nanocarbon serving as a carrier, and the nanocarbon contains a certain amount of carboxyl on the surface, and ferrous ions and/or ferric ions in an iron salt, wherein the carboxyl has a content range of 0.03 mmol/g-0.08 mmol/g, wherein the composite system has a particle size of 90-300 nm,
Dependencies are inferred from the claim text.